awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38221488-CE2D7EE5-9C51-44D3-A12C-C5C2C1A67A53
Q38221488-CE2D7EE5-9C51-44D3-A12C-C5C2C1A67A53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221488-CE2D7EE5-9C51-44D3-A12C-C5C2C1A67A53
Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.
P2860
Q38221488-CE2D7EE5-9C51-44D3-A12C-C5C2C1A67A53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38221488-CE2D7EE5-9C51-44D3-A12C-C5C2C1A67A53
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da4ae73cbceae93fe61f75ef5c7d249e242e9c1e
P2860
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.